share_log

Recent 17% Pullback Isn't Enough to Hurt Long-term Shandong Fengyuan Chemical (SZSE:002805) Shareholders, They're Still up 95% Over 5 Years

Recent 17% Pullback Isn't Enough to Hurt Long-term Shandong Fengyuan Chemical (SZSE:002805) Shareholders, They're Still up 95% Over 5 Years

最近17%的回調不足以傷害山東豐源化學(SZSE:002805)的長期股東,他們在5年內仍上漲了95%
Simply Wall St ·  01/30 17:12

Some Shandong Fengyuan Chemical Co., Ltd. (SZSE:002805) shareholders are probably rather concerned to see the share price fall 33% over the last three months. On the bright side the returns have been quite good over the last half decade. Its return of 93% has certainly bested the market return! While the long term returns are impressive, we do have some sympathy for those who bought more recently, given the 62% drop, in the last year.

過去三個月中國山東豐元化工股份有限公司(股票代碼:SZSE:002805)的股價下跌了33%,這對於股東來說可能比較擔心。但是好在過去五年的回報還是相當不錯的,回報率高達93%,當然比市場平均水平高得多!儘管長期回報令人印象深刻,但是在過去一年裏,股價下跌了62%,我們對最近才買入該公司股票的股民感到遺憾。

While this past week has detracted from the company's five-year return, let's look at the recent trends of the underlying business and see if the gains have been in alignment.

雖然過去的一週削弱了公司的五年回報,但讓我們看看業務的最近趨勢,並查看收益是否已對齊。

Check out our latest analysis for Shandong Fengyuan Chemical

歡迎查看我們對中國山東豐元化工股份有限公司的最新分析

Because Shandong Fengyuan Chemical made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. Some companies are willing to postpone profitability to grow revenue faster, but in that case one does expect good top-line growth.

因爲中國山東豐元化工股份有限公司在過去12個月內虧損,所以我們認爲,市場現在可能更加關注營收和營收增長。一般來說,沒有盈利的公司每年都被認爲應該實現營收增長,並且速度應該相當快。一些公司願意犧牲盈利來實現更快的營收增長,但在這種情況下,人們期望公司的營收增長預計應該非常快。

In the last 5 years Shandong Fengyuan Chemical saw its revenue grow at 49% per year. That's well above most pre-profit companies. While the compound gain of 14% per year is good, it's not unreasonable given the strong revenue growth. If you think there could be more growth to come, now might be the time to take a close look at Shandong Fengyuan Chemical. Of course, you'll have to research the business more fully to figure out if this is an attractive opportunity.

在過去的5年裏,中國山東豐元化工股份有限公司的營業收入年均增長率爲49%,這遠高於大多數未盈利的公司。雖然14%的複合收益率不錯,但考慮到強勁的營業收入增長,在這種情況下也並不算過分。如果您認爲公司有更大的增長空間,那麼現在可能是仔細觀察中國山東豐元化工股份有限公司的時候了。當然,要想確定這是否是有吸引力的投資機會,您必須對該公司進行更深入的調查。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

你可以在下面的圖片中看到收入和營業收入隨時間的變化情況(單擊圖表可查看精確值)。

earnings-and-revenue-growth
SZSE:002805 Earnings and Revenue Growth January 30th 2024
SZSE:002805營收增長截止2024年1月30日。

It's probably worth noting that the CEO is paid less than the median at similar sized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. This free interactive report on Shandong Fengyuan Chemical's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

值得注意的是,該公司的CEO的薪酬低於同等規模公司的薪酬中位數。監督CEO的薪酬總是值得的,但更重要的問題是公司是否會在未來多年內增加收益。如果您想進一步調查這隻股票,可以在這裏免費交互式報告中查看中國山東豐元化工股份有限公司的收益、營收和現金流。

A Different Perspective

不同的觀點

We regret to report that Shandong Fengyuan Chemical shareholders are down 62% for the year (even including dividends). Unfortunately, that's worse than the broader market decline of 20%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. On the bright side, long term shareholders have made money, with a gain of 14% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For instance, we've identified 2 warning signs for Shandong Fengyuan Chemical (1 shouldn't be ignored) that you should be aware of.

很遺憾地通報,中國山東豐元化工股份有限公司的股東在過去的一年中(包括分紅派息)虧損了62%。不幸的是,這比市場的整體下跌幅度達到了20%。然而,可能只是股價受到了市場整體情緒的影響。如果有機會,值得密切關注該公司的基本面。但值得慶幸的是,長期的股東已經賺到了錢,回報率爲每年14%。最近的拋售行情可能是一個機會,因此,檢查基本數據是否存在長期增長趨勢的跡象可能值得一試。我認爲,通過長期觀察股票價格以代表業務表現是非常有趣的。但要真正獲得深入的見解,我們需要考慮其他信息。例如,我們已經確定了兩個警告信號對於中國山東豐元化工股份有限公司(其中一個不應忽視)您應該知道。

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

對於那些喜歡尋找獲勝投資的人,這個具有最近內部購買的增長型公司免費列表可能是您的不二選擇。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論